Additional insights


  • Reiter et al., "2013 Year-In-Review: Patent Cases at the Federal Circuit," Industrial Biotech. 10(2):79-82 (2014)
  • Reiter et al., "Patent eligibility of biological methods and compositions," Industrial Biotech. 9(3):90-92 (2013)
  • Reiter et al., "The America Invents Act and Its Importance to Patent Prosecution in the Biotech Sector," Industrial Biotech. 8(2):66-69 (2012)
  • Reiter et al., "The Federal Circuit Court of Appeals decides that isolated DNA claims are patentable," Industrial Biotech. 9(3):272-275 (2011)
  • Reiter et al., "Strategies for expediting examination in U.S. patent applications," Industrial Biotech. 7(5):349-353 (2011)
  • Reiter et al., "Isolated, purified, covalent bonds, or magic microscopes? What defines patentable nucleic acid molecules?" Industrial Biotech. 7(3):196-199 (2011)
  • Reiter et al., "Heme oxygenase-1 overexpression blocks NO-induced necrosis by preventing lipid peroxidation in human pulmonary epithelial cells," J. Biol. Chem.  281(48):36603-36612, (2006)
  • Reiter et al., "Electrochemical studies of the mono-Fe, Fe-Zn, and Fe-Fe metalloisoforms of bacteriophage protein phosphatase," Biochemistry 43: 782-790 (2003)
  • Reiter et al., "Mn2+ is a native metal ion activator for bacteriophage protein phosphatase," Biochemistry 41:15404-15409 (2002)
  • Reiter et al., "Is calcineurin a peroxide-sensor in T-lymphocytes?" J. Biol. Inorg. Chem. 7: 823-834 (2002)
  • Reiter et al., "Redox regulation of calcineurin in T-lymphocytes," J. Biol. Inorg. Chem. 4: 632-644 (1999)